Focus launches a special issue dedicated to cancer research
The magazine contains a report on the latest news of Italian excellence in the fight against cancer: from gene therapies to Artificial Intelligence
Focus, the Mondadori Group brand that’s the leader in popular science, is on the newsstands this month with a special issue dedicated to the latest advances in cancer research.
An updated guide full of insights to let readers discover the latest innovations and therapies, including experimental and anti-cancer: from the analysis of DNA alterations to vaccines, from proton therapy to targeted treatments that are more customised and effective, as well as the tools and perspectives that Artificial Intelligence can offer in this field.
A report – created with the collaboration of specialists from the most important Italian universities and centres of excellence at the forefront of cancer research worldwide – which underlines the role of Focus as a leading magazine for an audience of readers and users who are passionate about the great scientific and technological issues, including in the field of medical information.
Thanks to a clear and direct style and a careful and dynamic look at everything that is innovation, the brand reaches an audience of 5.5 million readers and users and 3.6 million followers on social networks every month.
“What emerges today with increasing evidence from oncological research,” says Raffaele Leone, Director of Focus, “is the variety of treatments and therapeutic approaches”. Cancer is a disease that has always been with us, a ‘malignant natural error’ that is nevertheless facilitated by harmful habits (smoking being the most typical) and pollution in the surrounding environment. It is a cellular mutation that often has the ability to camouflage itself so as not to be intercepted and neutralised. Today we are able to invent increasingly customised and targeted cures against the various types of mutation, to unmask them and attack them”, concludes Leone.
In the new issue of Focus we will talk about projects with an international scope, such as Palm (Pediatric Acute Leukemia of Myeloid origin), but also Italian projects such as the Molecular Tumor Board, a national network to standardise procedures and create a network of consultancies throughout the country.
Through numerous fact sheets – which have also been created thanks to the contribution of scientists and experts – the most widely read monthly magazine in Italy sheds light on the importance of prevention through vaccines against Hepatitis B and HPV, and the possibility for smokers to get free lung scans with the aim of raising awareness and giving hope.
The creation of such a rich and in-depth report has been possible thanks to constant contact with research institutes, universities, hospitals and foundations, which Focus has always collaborated with to keep its readers informed and updated.
This issue made use of the valuable collaboration of:
IRCCS Istituto Clinico Humanitas [Humanitas Clinical Institute Research Hospital]
San Raffaele Hospital
National Cancer Institute
European Institute of Oncology
Umberto Veronesi Foundation
RevoLuTion_Innovation in Cancer Care
And it involved:
Vita-Salute San Raffaele University
Italian Association of Medical Oncology
Centro di riferimento oncologico (CRO) di°Aviano [Aviano Oncology Referral Centre]
Centro di Senologia del Policlinico San Martino di Genova [Centre for Senology of Hospital Policlinico San Martino of Genoa]
Oncohematology Clinic of Padua
MD Anderson Cancer Center in Houston
Bambino Gesù Children’s Research Hospital
Italian Pulmonary Screening Network
Italian Society of Oncological Urology
University of Milan
University of Palermo
University of Turin
University of Melanoma, Oncological Immunotherapy and Innovative Therapies IRCCS INT-Pascale Foundation of Naples